RESEZIONE ILEOCOLICA PER CROHN. MEGLIO LA RESEZIONE “ESTESA” DEL MESENTERE: RIDUCE IL RISCHIO DI RECIDIVA ENDOSCOPICA RISPETTO ALLA RESEZIONE LIMITATA. IL GRANDE TRIAL MESOCOLIC. DA”GASTROENTEROLOGY”

CHIRURGIA, GASTROENTEROLOGIA, IBD, NEWSLETTER

Postoperative Endoscopic Outcomes in the MESOCOLIC Trial Investigating Mesenteric-Based Surgery for Crohn’s Disease Ming Duan et al. Crohn’s disease (CD) is incurable, with high postoperative recurrence rates even after resection.1 Mesenteric fat, nerves, and lymphatics are important in the pathobiology and progression of CD.2,3 The multicenter randomized Mesenteric Excision Surgery or Conservative Limited Resection in Crohn’s…

ATTENZIONE PANCREATOLOGI! ASPIRINA RIDUCE IL RISCHIO DI K DEL PANCREAS NEL DIABETICO! UNO STUDIO RETROSPETTIVO SU 300.000 PAZIENTI DA “GUT”

CHIRURGIA, GASTROENTEROLOGIA, MEDICINA INTERNA, NEWSLETTER, PANCREAS E VIE BILIARI, Senza categoria

Aspirin is associated with lower risk of pancreatic cancer and cancer-related mortality in patients with diabetes mellitus Jing Tong Tan et al. Abstract Background Patients with type 2 diabetes mellitus (T2DM) have higher pancreatic cancer (PC) risk. While aspirin has chemopreventive effects on digestive cancers, its effect on PC among patients with T2DM is unclear. Methods This…

EPATITE AUTOIMMUNE: UNA MAGNIFICA REVISIONE 2025 DA “JOURNAL OF HEPATOLOGY” (FREE!)

EPATOLOGIA, GASTROENTEROLOGIA, NEWSLETTER

Update in clinical science: Autoimmune hepatitis Michael A. Heneghan Ansgar Wilhelm Lohse Summary Autoimmune hepatitis (AIH) is an enigmatic, relatively rare disease with a variable spectrum of presentation whose pathogenesis, diagnosis and management remain a major challenge. We have performed a review of recent developments in basic science, epidemiology, clinical science, therapeutics, and regulatory science, evaluating the challenges…

PROTEGGERE IL MICROBIOTA DAGLI ANTIBIOTICI! IL FUTURO E’ QUI! LEGGETE DA “NATURE” (FREE!)

MEDICINA DEI PROBIOTICI, NEWSLETTER

The researchers on a quest to protect the gut from antibiotics The crucial drugs can have unintended consequences. Innovative therapies could shield the microbiome from their effects. Elie Dolgin James Collins, Andrés Cubillos-Ruiz and Raphaël Gayet co-founded the biotechnology company Florey Biosciences.Credit: Andrés Cubillos-Ruiz’s wife was four months pregnant when she received a course of…

AI: LA DIAGNOSI IMAGING-BASED DEL CANCRO ESOFAGEO E GASTRICO. UNA REVISIONE DELLE APPLICAZIONI DELLA INTELLIGENZA ARTIFICIALE ! DA”GASTROENTEROLOGY” (FREE!)

AI, INTELLIGENZA ARTIFICIALE, CHIRURGIA, DIAGNOSTICA PER IMMAGINI, ECOGRAFIA ED ECOENDOSCOPIA, ENDOSCOPIA, NEWSLETTER

Artificial Intelligence Applications in Image-Based Diagnosis of Early Esophageal and Gastric Neoplasms Alanna Ebigbo∙ Helmut Messmann ∙ Sung Hak Lee Abstract Artificial intelligence (AI) holds the potential to transform the management of upper gastrointestinal (GI) conditions, such as Barrett’s esophagus, esophageal squamous cell cancer, and early gastric cancer. Advancements in deep learning (DL) and convolutional neural networks offer improved…

ERAS (ENHANCED RECOVERY AFTER SURGERY): UNA REVISIONE SULLE ULTIME EVIDENZE 2025 ! DA” NEJM EVIDENCE” (FREE!)

CHIRURGIA, GASTROENTEROLOGIA, NEWSLETTER, NUTRIZIONE

Enhanced Recovery after Surgery — Evidence and Practice Kevin M. Elias, M.D., Mary E. Brindle, M.D., M.P.H., and Gregg Nelson, M.D., Ph.D. Abstract Enhanced Recovery After Surgery (ERAS) is a global initiative comprised of a series of evidence-based interventions in the preoperative, intraoperative, and postoperative surgical phases. When implemented as a bundle, ERAS interventions both improve clinical outcomes and provide cost…